Summary of Key Points from the Conference Call Industry Overview - The methionine industry is experiencing significant supply disruptions due to a 17% decrease in Qatar's MG production and geopolitical conflicts, leading to a risk of natural gas supply interruptions for 30% of Europe's methionine production capacity. This shift is causing a global supply tilt towards China [1][2]. - The industry is characterized by an oligopolistic structure, with major players including Evonik, Adisseo, and New Hope, holding a combined market share of over 70% [1][5]. - Global nominal methionine capacity is approximately 2.5 million tons, while demand stands at around 1.7 million tons, indicating a long-term oversupply situation [1][5]. Price Dynamics - Methionine prices have surged from 17-19 CNY/kg to 31-34 CNY/kg, reflecting a price increase of 70%-80% driven by rising costs and geopolitical factors [1][6]. - The price increase is attributed to the rapid rise in upstream raw material costs, particularly sulfur, and the impact of geopolitical tensions [6]. Supply Chain and Demand - The downstream demand for methionine is robust, particularly in the livestock sector, where adding 0.2% methionine can reduce chicken production costs by over 20%. The expected annual compound growth rate for the industry is projected to be 5%-6% [1][3][4]. - The global methionine market is segmented, with the Americas being relatively stable and less affected by current geopolitical issues. However, the remaining global demand of approximately 1.4 million tons may heavily rely on Chinese production if European capacity is disrupted [7]. Company-Specific Insights New Hope - New Hope has a methionine production capacity of 520,000-530,000 tons, with strong cost control and expectations for incremental capacity growth [1][8]. Adisseo - Adisseo, a leading global methionine producer, has a total capacity of 710,000 tons, with significant production facilities in Nanjing and plans for a 150,000-ton project in Quanzhou, which may accelerate its timeline for completion [1][9]. Hebang Biotechnology - Hebang Biotechnology has developed a liquid methionine capacity of 70,000 tons, leveraging natural gas resources in the Sichuan-Chongqing region. The company is well-positioned to benefit from high price levels in the methionine market [1][10]. Geopolitical Impact - The volatility in the natural gas market, exacerbated by Middle Eastern conflicts, poses a significant risk to the methionine industry, particularly in Europe, where production is heavily reliant on natural gas and other oil-related raw materials [2][7]. Conclusion - The methionine industry is at a critical juncture, with supply chain disruptions and price volatility creating both challenges and opportunities for key players. The reliance on Chinese production capacity may increase, and companies with strong cost control and production capabilities are likely to benefit in the current market environment [1][2][7].

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [3][4]. Core Insights - High oil prices are expected to sustain, leading to expanded arbitrage opportunities in coal chemical and natural gas chemical sectors. The price of methionine continues to rise due to strong demand, and positive feedback from the CAC Agricultural Exhibition is noted [3][4]. - The report suggests focusing on companies such as Baofeng Energy, Hualu Hengsheng, Luxi Chemical, Satellite Chemical, and Wanhua Chemical due to favorable market conditions [3][4]. Summary by Sections Macro Economic Judgments - Oil prices are likely to remain high due to geopolitical tensions affecting supply routes. Coal prices are stabilizing at a low point, while natural gas prices are expected to rise temporarily due to conflicts, with potential for reduced import costs as the U.S. accelerates natural gas export facility construction [3][4]. Chemical Sector Configuration - The report highlights the expansion of arbitrage opportunities in coal and natural gas chemicals, with natural gas arbitrage space at $12.11 per million British thermal units and coal arbitrage at 844 RMB per ton, both showing significant increases since the beginning of the year [3][4]. - The report emphasizes the importance of the agricultural chemical chain, with steady growth in fertilizer demand and rising prices for various pesticide products due to supply tightness and seasonal demand [3][4]. Investment Analysis - The report recommends a diversified investment strategy focusing on four areas: alternative energy (coal and natural gas chemicals), agricultural chemicals, fine chemicals with high overseas production ratios, and sectors with improving supply-demand dynamics [3][4]. - Specific companies to watch include Xinjiang Tianye and Wanwei High-tech in the PVA sector, and Yangnong Chemical and Anpon in the agricultural chemicals sector [3][4]. Key Material Focus - The report identifies key materials for growth, including semiconductor materials, OLED panel materials, and lithium battery materials, suggesting companies like Yake Technology and Dinglong Co. for investment opportunities [3][4].

Group 1: Company Overview and Strategy - The company aims to enhance product competitiveness and focus on new markets, businesses, products, and customers in 2026 [3] - The operational philosophy emphasizes "expanding markets, innovative development, intelligent manufacturing, and improving quality and efficiency" [3] Group 2: Production Capacity and Market Trends - The company has a solid methionine production capacity of 10,000 tons/year and a joint venture project with Sinopec for 180,000 tons/year of liquid methionine, which has commenced production [3] - Recent market trends indicate an increase in methionine prices due to global supply-demand dynamics [3] Group 3: Vitamin Production and Market Position - The company is a major global producer of vitamins, capable of producing 13 types, primarily used in feed additives, food additives, and nutritional health [4] - The company plans to optimize production processes and enhance capacity utilization to achieve sustainable growth [4] Group 4: Biochemical and New Materials Development - The company is advancing its "Chemicals+" and "Biological+" technology platforms, focusing on products like Vitamin C, Coenzyme Q10, and various amino acids [4] - A new nylon materials project in Tianjin is expected to be completed by 2027, enhancing the company's new materials segment [4] Group 5: Supply Chain and Cost Management - The company employs strategic procurement and long-term cooperation to stabilize raw material supply and manage costs effectively [5] - The impact of raw material price fluctuations on production costs is manageable due to the diverse product structure [5] Group 6: Export Markets and Global Strategy - The company exports to over 100 countries, with exports accounting for more than 50% of its business, covering major regions like Europe, Southeast Asia, and the Americas [6] - The company aims to deepen its global market expansion and enhance competitiveness in overseas markets [6] Group 7: Cost Competitiveness - The company focuses on integrated, series, and collaborative development strategies to strengthen cost competitiveness [6] - Efforts include optimizing production loads, enhancing operational efficiency, and leveraging technological advancements for cost reduction [6]

1. Report Industry Investment Rating - No information provided in the given content 2. Core View of the Report - The tense situation in the Middle East has caused high - level fluctuations in oil prices, which in turn drives up the overall prices of chemical products [1] 3. Summary by Relevant Catalogs 3.1 Basic Chemical Weekly Data Briefing 3.1.1 Related Company Performance Tracking - The Basic Chemical Index had a 0.6% increase in the past week, 5.4% in the past month, 27.1% in the past three months, 49.5% in the past year, and 19.2% since the beginning of 2026 [8] - Among related companies, the stock prices of Baofeng Energy had significant increases, with a 21.2% increase in the past week, 44.6% in the past month, 95.6% in the past three months, 112.9% in the past year, and 76.8% since the beginning of 2026; while Wanhua Chemical's stock price decreased by 9.1% in the past week [8] 3.1.2 Related Company Profit Tracking - The total market value, net profit attributable to the parent company, PE, and PB of companies such as Wanhua Chemical, Baofeng Energy, Satellite Chemical, Hualu Hengsheng, New Hope Liuhe, and Adisseo were presented, with some data being the forecasts of Soochow Securities Research Institute [8] 3.1.3 Industry Chain Data - **Polyurethane Industry Chain**: The weekly average prices of pure MDI, polymer MDI, and TDI were 20457 yuan/ton, 16500 yuan/ton, and 17996 yuan/ton respectively, with month - on - month increases of 2114 yuan/ton, 1893 yuan/ton, and 2283 yuan/ton respectively; the corresponding gross profits were 5175 yuan/ton, 2218 yuan/ton, and 4510 yuan/ton, with month - on - month changes of +576 yuan/ton, +355 yuan/ton, and - 33 yuan/ton respectively [2][8] - **Oil - Gas - Olefin Industry Chain**: The average prices of ethane, propane, steam coal, and naphtha were 1250 yuan/ton, 6376 yuan/ton, 520 yuan/ton, and 6435 yuan/ton respectively, with month - on - month increases of 44 yuan/ton, 887 yuan/ton, 0 yuan/ton, and 1211 yuan/ton respectively. The average price of polyethylene was 8865 yuan/ton, with a month - on - month increase of 1215 yuan/ton; the theoretical profits of ethane cracking, CTO, and naphtha cracking to produce polyethylene were 1997 yuan/ton, 2556 yuan/ton, and - 1426 yuan/ton respectively, with month - on - month changes of +753 yuan/ton, +793 yuan/ton, and - 383 yuan/ton respectively. The average price of polypropylene was 8910 yuan/ton, with a month - on - month increase of 1640 yuan/ton; the theoretical profits of PDH, CTO, and naphtha cracking to produce polypropylene were - 781 yuan/ton, 2798 yuan/ton, and - 1028 yuan/ton respectively, with month - on - month changes of +306 yuan/ton, +1088 yuan/ton, and - 89 yuan/ton respectively [2][8] - **Coal - Chemical Industry Chain**: The average prices of synthetic ammonia, urea, DMF, and acetic acid were 2087 yuan/ton, 1839 yuan/ton, 5114 yuan/ton, and 2767 yuan/ton respectively, with month - on - month increases of 62 yuan/ton, 21 yuan/ton, 1005 yuan/ton, and 191 yuan/ton respectively; the corresponding gross profits were 88 yuan/ton, 154 yuan/ton, 428 yuan/ton, and 383 yuan/ton, with month - on - month increases of 63 yuan/ton, 5 yuan/ton, 169 yuan/ton, and 4 yuan/ton respectively [2][10] - **Animal Nutrition Industry Chain**: The average prices of VA, VE, solid methionine, and liquid methionine were 64.9 yuan/kg, 73.1 yuan/kg, 31.6 yuan/kg, and 19.0 yuan/kg respectively, with month - on - month increases of 4.4 yuan/kg, 9.7 yuan/kg, 10.7 yuan/kg, and 3.3 yuan/kg respectively [2][10] 3.2 Basic Chemical Weekly Report 3.2.1 Basic Chemical Index Trend - No detailed data provided in the given content 3.2.2 Polyurethane Plate - Analyzed the price trends and price - spread situations of pure MDI, polymer MDI, and TDI in China [15][18] 3.2.3 Oil - Gas - Olefin Plate - Studied the price trends of MB ethane, NYMEX natural gas, domestic steam coal, naphtha, crude oil, and propane, as well as the profitability of different processes such as ethane cracking to produce PE, PDH to produce PP, coal - to - PE, coal - to - PP, and naphtha - to - PE/PP [22][23][26][28][29][34][36][37] 3.2.4 Coal - Chemical Plate - Analyzed the price and gross - profit trends of coal - coking products (coking coal, coke), traditional coal - chemical products (synthetic ammonia, methanol, urea, DMF, acetic acid), and new materials (DMC, oxalic acid, octanol, adipic acid, caprolactam, PA6, PA66) [10][39][40][42][46][48][51][53] 3.2.5 Animal Nutrition Plate - Studied the price trends of VE, solid methionine, and liquid methionine [54][56]

Core Insights - The 2026 Hurun Global Rich List highlights the growing influence of Chinese private equity investors, reflecting the maturation of China's capital markets and the redefinition of the asset management industry [2] Group 1: Wealth Rankings - Shen Nanpeng of Sequoia China ranks 785th with a wealth of 40 billion RMB [3] - Ge Weidong of Chaos Investment ranks 871st with a wealth of 35.5 billion RMB [10] - Zhang Lei of Hillhouse Capital ranks 1013th with a wealth of 26.5 billion RMB [7] - Duan Yongping of H&H International ranks 2207th with a wealth of 14.5 billion RMB [12] - Qiu Guogen and Luo Yifu of Chongyang Investment rank 3635th with a wealth of 7.5 billion RMB [4] Group 2: Investment Strategies and Achievements - Qiu Guogen and Luo Yifu have successfully managed Chongyang Investment, with a significant focus on long-term investments, exemplified by their 6 billion RMB investment in Xinhecheng, yielding over 1 billion RMB in profits over eight years [5][6] - Zhang Lei's Hillhouse Capital has grown to manage over 500 billion USD, with notable investments in companies like JD.com and Blue Moon, emphasizing the importance of logistics and supply chain in competitive advantage [8][9] - Ge Weidong's investment strategies in futures have led to significant profits, including a notable gain during the cotton futures market in 2010 and the "copper futures battle" in 2014, showcasing his market acumen [11] - Duan Yongping's investment philosophy emphasizes value investing, with a focus on companies like Apple and Tencent, and he has a significant presence in the U.S. stock market with a portfolio valued at approximately 17.49 billion USD [12][13][14] Group 3: Notable Investments and Market Impact - Shen Nanpeng's Sequoia China has invested in over 1500 companies, with more than 160 having gone public, reflecting a broad investment strategy across various sectors [15][16] - The investment landscape is increasingly characterized by a focus on technology and consumer sectors, with major players like Hillhouse and Sequoia leading the charge in identifying high-potential opportunities [15][16]

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][7]. Core Viewpoints - The price of methionine and vitamin E has increased significantly, with methionine prices rising by 84.66% and vitamin E by 40.54% since the beginning of the year [2]. - The global methionine production capacity is approximately 2.7 million tons per year, with 44% of this capacity facing challenges outside of China and the US, particularly in Europe and Asia [2][3]. - The rising costs of raw materials and energy, including a 29% increase in Brent crude oil prices and a 56% increase in Dutch TTF natural gas prices, are expected to continue affecting production costs [3][8]. - The methionine and vitamin E industries are characterized by oligopolistic market structures, allowing major companies to exert pricing power [3][9]. - New Hope Liuhe, as the third-largest methionine producer and the largest vitamin E producer globally, is well-positioned to benefit from the price increases in these products [4][19]. Summary by Relevant Sections Methionine Market - The demand for methionine is expected to grow at a compound annual growth rate (CAGR) of 5.21% from 2014 to 2024, increasing from 1.023 million tons to 1.7 million tons [5]. - The production capacity distribution shows that China accounts for approximately 40% of global methionine capacity, while Europe and Asia (excluding China) account for over 40% combined [6]. Vitamin E Market - The global vitamin E market is highly concentrated, with only six major producers controlling 92% of the market [16]. - The price of vitamin E has also seen a significant increase, with a 40.54% rise since the beginning of the year [18]. Financial Projections - The company is expected to achieve net profits of 6.792 billion yuan in 2025, 7.248 billion yuan in 2026, and 7.737 billion yuan in 2027, with corresponding price-to-earnings ratios of 17.8, 16.7, and 15.6 [19][23].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][7]. Core Viewpoints - The price of methionine and vitamin E has increased significantly, with methionine prices rising by 84.66% and vitamin E by 40.54% since the beginning of the year [2]. - The global methionine production capacity is approximately 2.7 million tons per year, with 44% of the capacity outside of China and the US facing challenges due to rising raw material prices and shortages [2][3]. - Major producers of methionine and vitamin E are experiencing production challenges due to high energy and raw material costs, particularly in Europe and Asia [3][4]. - The oligopolistic nature of the methionine and vitamin E industries allows leading companies to maintain pricing power, with strong demand from downstream applications [3][4]. - The company is positioned to benefit from the rising prices of methionine and vitamin E, being the third-largest producer of methionine and the largest producer of vitamin E globally [4]. Summary by Sections Market Conditions - As of March 12, the market prices for methionine and vitamin E are 32.5 and 78 RMB per kilogram, respectively, reflecting significant increases from earlier in the year [2]. - The production capacity of methionine is concentrated, with the top three companies accounting for about 71% of the market [9]. Cost Structure - The production costs for methionine have risen sharply due to increases in the prices of key raw materials such as natural gas, methanol, and sulfur [3][8]. - The cost of methionine in poultry feed is relatively low, allowing producers to pass on cost increases to downstream customers effectively [10]. Financial Projections - The company is expected to see a significant increase in net profit, with projections of 67.92 billion RMB for 2025 and 72.48 billion RMB for 2026, corresponding to a price-to-earnings ratio of 17.8 and 16.7, respectively [19].

Investment Rating - The report maintains a "B" rating for the new materials sector, indicating a leading position in the market [2]. Core Insights - The new materials sector has experienced a decline, with the new materials index dropping by 5.28%, underperforming the ChiNext index by 2.83% [3][12]. - The ongoing geopolitical tensions in the Middle East, particularly the disruption of commercial shipping in the Strait of Hormuz, have created opportunities in the vitamin and amino acid industries due to supply shortages and rising prices [5]. - Key products such as Vitamin E and methionine have shown significant price increases, with Vitamin E reaching 66,500 CNY/ton (up 11.8% week-on-week) and methionine at 23,850 CNY/ton (up 24.54% week-on-week) [5]. Summary by Sections 1. Market Performance - The new materials sector has seen a downturn, with various sub-sectors such as semiconductor materials and electronic chemicals experiencing declines of 9.92% and 7.39% respectively over the past five trading days [3][16]. - The overall performance of the basic chemicals and new materials sectors has been negative, with the Shanghai Composite Index and ChiNext Index also showing declines [12]. 2. Price Tracking - Amino acids: Valine at 13,400 CNY/ton (-0.74%), arginine at 22,000 CNY/ton (unchanged), tryptophan at 33,000 CNY/ton (+0.46%), and methionine at 23,850 CNY/ton (+24.54%) [4]. - Vitamins: Vitamin A at 60,500 CNY/ton (unchanged), Vitamin E at 66,500 CNY/ton (+11.76%), and Vitamin D3 at 192,500 CNY/ton (unchanged) [4]. - Industrial gases: UPSSS grade hydrofluoric acid at 11,000 CNY/ton (unchanged) and EL grade hydrofluoric acid at 6,385 CNY/ton (unchanged) [4]. 3. Investment Recommendations - The report suggests focusing on companies within the vitamin and amino acid supply chains, particularly due to the current market dynamics influenced by geopolitical factors [5]. - Recommended companies include Xinhecheng, Andisu, Meihua Biological, and Zhejiang Medicine, which are expected to benefit from the rising prices of core products [5].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 52.63, which is an increase of 38% from the previous target price of RMB 38.24 [1][4]. Core Insights - The report highlights that the geopolitical conflicts in the Middle East have led to increased prices and supply shortages of key raw materials such as LNG, methanol, propane/propylene, and sulfur, which are essential for the production of methionine. This instability in raw material supply is expected to drive up methionine prices, benefiting the company due to its relatively stable domestic raw material and energy supply [1][2]. - The company is projected to gain market share globally as its production capacity for methionine and vitamins is more competitive compared to overseas firms, especially in the context of declining overseas supply stability [1][3]. - The report anticipates a continued upward trend in methionine prices, with a forecasted net profit of RMB 67 billion, RMB 85 billion, and RMB 96 billion for the years 2025 to 2027, respectively, reflecting a compound annual growth rate (CAGR) of 18% [4]. Summary by Sections Supply and Demand Dynamics - Since the end of February, geopolitical tensions have caused price increases and supply shortages for raw materials like natural gas and sulfur, impacting overseas methionine production. Companies such as Winco and Sumitomo Chemical have declared force majeure due to these supply issues [2]. - The domestic methionine market price as of March 10 was RMB 28.75 per kg, a 63% increase since the beginning of the year, indicating a significant widening of the price gap compared to international markets [2]. Vitamin Market Outlook - The vitamin market, particularly for Vitamin E, has also shown signs of improvement, with prices rising to RMB 68.5 per kg, a 23% increase since the start of the year. The report suggests that supply constraints from overseas will further enhance the company's market position [3]. Financial Projections - The company’s projected revenues for 2024, 2025, 2026, and 2027 are RMB 21.61 billion, RMB 23.88 billion, RMB 27.88 billion, and RMB 31.05 billion, respectively, with corresponding net profits of RMB 5.87 billion, RMB 6.73 billion, RMB 8.51 billion, and RMB 9.63 billion [10][33]. - The report estimates an increase in the company's net profit forecasts for 2026 and 2027 by 16% and 19%, respectively, due to the anticipated rise in methionine prices [4].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 52.63, which is an increase of 38% from the previous target price of RMB 38.24 [1][4]. Core Views - The report highlights that the geopolitical conflicts in the Middle East have led to supply disruptions and price increases for key raw materials such as LNG, methanol, propane/propylene, and sulfur, which are essential for the production of methionine. This situation is expected to drive methionine prices upward, benefiting the company due to its stable domestic raw material and energy supply [1][2]. - The company is projected to gain market share globally as its production capacity for methionine and vitamins is more competitive compared to overseas firms, especially in light of the declining stability of overseas supply [1][3]. - The report anticipates a continued upward trend in methionine prices driven by increasing downstream demand and declining overseas supply, which positions the company favorably [2][3]. Summary by Sections Investment Rating - The company maintains a "Buy" rating with a target price of RMB 52.63, reflecting a 38% increase from the previous target [1][4]. Market Conditions - Geopolitical tensions have caused supply shortages and price hikes in essential raw materials, which are expected to benefit the company's methionine production [1][2]. - The global methionine production capacity is projected to be around 2.55 million tons by 2025, with domestic production accounting for approximately 40% [2]. Financial Projections - The company's net profit forecasts for 2025-2027 are adjusted to RMB 67 billion, RMB 85 billion, and RMB 96 billion respectively, with a compound annual growth rate (CAGR) of 18% [4]. - The report estimates that the company's earnings per share (EPS) will increase from RMB 1.91 in 2024 to RMB 3.13 in 2027 [10][33].